110 related articles for article (PubMed ID: 23565472)
1. A clinical study to compare the efficacy and safety of pregabalin sustained release formulation with pregabalin immediate release formulation in patients of diabetic peripheral neuropathic pain.
Srivastava A; Shah S; Maseeh A; Vyasa B; Balaji M; Bhatter S; Buch P; Dantara D; Karnani J; Kumar V; Lodha S; Maji D; Moses A; Phatak S; Polarappu S; Shah S; Upadhayay B
Indian J Endocrinol Metab; 2012 Dec; 16(Suppl 2):S477-9. PubMed ID: 23565472
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and Safety of a New Sustained-release Pregabalin Formulation Compared With Immediate-release Pregabalin in Patients With Peripheral Neuropathic Pain: A Randomized Noninferiority Phase 3 Trial.
Han KA; Lee YH; Son HS; Song KH; Kim SY; Chung CH; Jang HC; Lee KW; Cha BY; Song KH; Ko YK; Lee PB; Kim BJ; Kim S; An T; Kim YC
Clin J Pain; 2022 Feb; 38(5):343-350. PubMed ID: 35220330
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of pregabalin for peripheral neuropathic pain: results of an 8-week, flexible-dose, double-blind, placebo-controlled study conducted in China.
Guan Y; Ding X; Cheng Y; Fan D; Tan L; Wang Y; Zhao Z; Hong Z; Zhou D; Pan X; Chen S; Martin A; Tang H; Cui L
Clin Ther; 2011 Feb; 33(2):159-66. PubMed ID: 21444113
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and Safety of Pregabalin Prolonged Release-Etoricoxib Combination Compared to Etoricoxib for Chronic Low Back Pain: Phase 3, Randomized Study.
Yeole AB; Sree Ranga Lakshmi G; Selvakumar CJ; Goni VG; Nawal CL; Valya BJ; Patel BJ; Patel RD; Pawar ED; Panigrahi R; Kumar AY; Shintre SS; Devkare PH; Dharmadhikari SK; Choudhari SY; Doshi MS; Mehta SC; Joglekar SJ
Pain Ther; 2022 Dec; 11(4):1451-1469. PubMed ID: 36224489
[TBL] [Abstract][Full Text] [Related]
5. A randomized, active-controlled, parallel, open-label, multicenter, phase 4 study to compare the efficacy and safety of pregabalin sustained release tablet and pregabalin immediate release capsule in type II diabetic patients with peripheral neuropathic pain.
Kang SM; Hong JH; Ku BJ
Medicine (Baltimore); 2023 Apr; 102(17):e33701. PubMed ID: 37115054
[TBL] [Abstract][Full Text] [Related]
6. Pregabalin for the treatment of painful diabetic peripheral neuropathy: a double-blind, placebo-controlled trial.
Rosenstock J; Tuchman M; LaMoreaux L; Sharma U
Pain; 2004 Aug; 110(3):628-638. PubMed ID: 15288403
[TBL] [Abstract][Full Text] [Related]
7. An open-label, long-term study examining the safety and tolerability of pregabalin in Japanese patients with central neuropathic pain.
Onouchi K; Koga H; Yokoyama K; Yoshiyama T
J Pain Res; 2014; 7():439-47. PubMed ID: 25114584
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and tolerability of pregabalin using a flexible, optimized dose schedule in Korean patients with peripheral neuropathic pain: a 10-week, randomized, double-blind, placebo-controlled, multicenter study.
Moon DE; Lee DI; Lee SC; Song SO; Yoon DM; Yoon MH; Kim HK; Lee YW; Kim C; Lee PB
Clin Ther; 2010 Dec; 32(14):2370-85. PubMed ID: 21353106
[TBL] [Abstract][Full Text] [Related]
9. Duloxetine in patients with diabetic peripheral neuropathic pain in Japan: a randomized, doubleblind, noninferiority comparative study with pregabalin.
Enomoto H; Yasuda H; Nishiyori A; Fujikoshi S; Furukawa M; Ishida M; Takahashi M; Tsuji T; Yoshikawa A; Alev L
J Pain Res; 2018; 11():1857-1868. PubMed ID: 30271191
[TBL] [Abstract][Full Text] [Related]
10. A Randomized, Double-Blind Study of the Effects of a Sustained Release Formulation of Sodium Nitrite (SR-nitrite) on Patients with Diabetic Neuropathy.
Soin A; Bock G; Giordano A; Patel C; Drachman D
Pain Physician; 2018 Mar; 21(2):179-190. PubMed ID: 29565948
[TBL] [Abstract][Full Text] [Related]
11. Pregabalin for peripheral neuropathic pain: results of a multicenter, non-comparative, open-label study in Indian patients.
LYRICA Study Group
Int J Clin Pract; 2006 Sep; 60(9):1060-7. PubMed ID: 16939547
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety evaluation of pregabalin treatment over 52 weeks in patients with diabetic neuropathic pain extended after a double-blind placebo-controlled trial.
Satoh J; Yagihashi S; Baba M; Suzuki M; Arakawa A; Yoshiyama T
J Diabetes Investig; 2011 Nov; 2(6):457-63. PubMed ID: 24843530
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and Safety of the Controlled-release Pregabalin Tablet (GLA5PR GLARS-NF1) and Immediate-release Pregabalin Capsule for Peripheral Neuropathic Pain: A Multicenter, Randomized, Double-blind, Parallel-group, Active-controlled, Phase III Clinical Trial.
Lee MK; Jeon Y; Choi SS; Lee PB; Kim YC; Suh JH; Sim SE; Song SO; Ko Y; Yu JM; Min K; Lee JH
Clin Ther; 2020 Dec; 42(12):2266-2279. PubMed ID: 33272643
[TBL] [Abstract][Full Text] [Related]
14. Pain alleviation and patient-reported health outcomes following switching to pregabalin in individuals with gabapentin-refractory neuropathic pain in routine medical practice.
Saldaña MT; Pérez C; Navarro A; Masramón X; Rejas J
Clin Drug Investig; 2012 Jun; 32(6):401-12. PubMed ID: 22480279
[TBL] [Abstract][Full Text] [Related]
15. Pregabalin relieves symptoms of painful diabetic neuropathy: a randomized controlled trial.
Lesser H; Sharma U; LaMoreaux L; Poole RM
Neurology; 2004 Dec; 63(11):2104-10. PubMed ID: 15596757
[TBL] [Abstract][Full Text] [Related]
16. A prospective, open-label, multicentre study of pregabalin in the treatment of neuropathic pain in Latin America.
Xochilcal-Morales M; Castro EM; Guajardo-Rosas J; Obregón TN; Acevedo JC; Chucan JM; Plancarte-Sanchez R; Davila G; Wajsbrot D; Guerrero M; Vinueza R
Int J Clin Pract; 2010 Aug; 64(9):1301-9. PubMed ID: 20487048
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of efficacy and safety of gabapentin, duloxetine, and pregabalin in patients with painful diabetic peripheral neuropathy.
Devi P; Madhu K; Ganapathy B; Sarma G; John L; Kulkarni C
Indian J Pharmacol; 2012 Jan; 44(1):51-6. PubMed ID: 22345870
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of 5% lidocaine (lignocaine) medicated plaster in comparison with pregabalin in patients with postherpetic neuralgia and diabetic polyneuropathy: interim analysis from an open-label, two-stage adaptive, randomized, controlled trial.
Baron R; Mayoral V; Leijon G; Binder A; Steigerwald I; Serpell M
Clin Drug Investig; 2009; 29(4):231-41. PubMed ID: 19301937
[TBL] [Abstract][Full Text] [Related]
19. A randomized trial of pregabalin in patients with neuropathic pain due to spinal cord injury.
Cardenas DD; Nieshoff EC; Suda K; Goto S; Sanin L; Kaneko T; Sporn J; Parsons B; Soulsby M; Yang R; Whalen E; Scavone JM; Suzuki MM; Knapp LE
Neurology; 2013 Feb; 80(6):533-9. PubMed ID: 23345639
[TBL] [Abstract][Full Text] [Related]
20. Sustained-release pregabalin with methylcobalamin in neuropathic pain: an Indian real-life experience.
Dongre YU; Swami OC
Int J Gen Med; 2013; 6():413-7. PubMed ID: 23761981
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
